1. Systemic infection following intravesical therapy with BCG.
- Author
-
Oliveira AA, Morais J, Ribeiro J, and Gouveia PF
- Subjects
- Administration, Intravesical, Humans, Immunotherapy, BCG Vaccine adverse effects, Sepsis, Urinary Bladder Neoplasms drug therapy
- Abstract
Immunotherapy with BCG is an effective and widely used treatment for non-muscle-invasive bladder cancer. BCG sepsis is a rare but life-threatening and frequently not a straightforward complication of this treatment; in cases with a high index of suspicion, anti-bacillary treatment should not wait for laboratory confirmation and be instituted immediately. We report a severe case of BCG sepsis, in which timely diagnosis and initiation of antituberculosis agents enabled a full recovery., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF